Jazz Pharmaceuticals plc buy JPMorgan Chase & Co.
Start price
29.02.24
/
50%
€109.35
Target price
28.02.25
€157.28
Performance (%)
-8.86%
Price
04.10.24
€99.66
Summary
This prediction is currently active. With a performance of -8.86%, the BUY prediction for Jazz Pharmaceuticals plc by JPMorgan_Chase___Co_ is down slightly. This prediction currently runs until 28.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 1.178% | 1.178% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at JPMorgan Chase & Co. from $180.00 to $170.00. They now have an "overweight" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€102.30
19.08.24
19.08.24
€182.69
19.08.25
19.08.25
-4.16%
04.10.24
04.10.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€112.05
25.03.24
25.03.24
€175.31
25.03.25
25.03.25
-11.06%
04.10.24
04.10.24